BioCorRx Revenue vs. Net Income
BioCorRx Net Income vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioCorRx's current stock value. Our valuation model uses many indicators to compare BioCorRx value to that of its competitors to determine the firm's financial worth. BioCorRx is the top company in revenue category among its peers. It is rated third in net income category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioCorRx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioCorRx's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioCorRx Revenue vs. Competition
BioCorRx is the top company in revenue category among its peers. Market size based on revenue of Medical Care Facilities industry is currently estimated at about 52.19 Million. BioCorRx adds roughly 48,272 in revenue claiming only tiny portion of all equities under Medical Care Facilities industry.
BioCorRx Net Income vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
BioCorRx |
| = | 48.27 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
BioCorRx |
| = | (5.21 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
BioCorRx Net Income Comparison
BioCorRx is currently under evaluation in net income category among its peers.
BioCorRx Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioCorRx, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioCorRx will eventually generate negative long term returns. The profitability progress is the general direction of BioCorRx's change in net profit over the period of time. It can combine multiple indicators of BioCorRx, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.
BioCorRx Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioCorRx. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioCorRx position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioCorRx's important profitability drivers and their relationship over time.
BioCorRx Earnings per Share Projection vs Actual
Use BioCorRx in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioCorRx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCorRx will appreciate offsetting losses from the drop in the long position's value.BioCorRx Pair Trading
BioCorRx Pair Trading Analysis
The ability to find closely correlated positions to BioCorRx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioCorRx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioCorRx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioCorRx to buy it.
The correlation of BioCorRx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioCorRx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioCorRx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioCorRx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioCorRx position
In addition to having BioCorRx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gambling Thematic Idea Now
Gambling
Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioCorRx OTC Stock Analysis
When running BioCorRx's price analysis, check to measure BioCorRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCorRx is operating at the current time. Most of BioCorRx's value examination focuses on studying past and present price action to predict the probability of BioCorRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCorRx's price. Additionally, you may evaluate how the addition of BioCorRx to your portfolios can decrease your overall portfolio volatility.